Sunday, 16 December 2012

Hard-to-treat Myc-Driven Cancers May Be Susceptible To Drug Already Used In Clinic

The mTORC1 inhibitor everolimus is used to treat various medical conditions. Everolimus prevented disease development in a mouse model of Myc-driven lymphoma. Treatment led to tumor regression in mice by inducing cellular senescence...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/KT1DVg9lp-c/254090.php

medical rehab sport

No comments:

Post a Comment